What if you'd held AVTX?
A $1,000 investment in Avalo Therapeutics, Inc. (AVTX) at the month-end close of 2015-10 would be worth $1.26 at the close of 2026-08 — -99.9% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $3,707.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2015
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2015 | $1,000 | — |
| 2016 | $263 | -73.7% |
| 2017 | $955 | +263.6% |
| 2018 | $964 | +0.9% |
| 2019 | $1,609 | +66.9% |
| 2020 | $788 | -51.0% |
| 2021 | $507 | -35.6% |
| 2022 | $125 | -75.3% |
| 2023 | $0.94 | -99.2% |
| 2024 | $0.77 | -18.4% |
| 2025 | $1.88 | +144.4% |
| 2026 | $2.15 | +14.3% |
Best and worst month-end to buy
The best single month-end close to have bought AVTX was 2025-05 ($4.00): $1,000 then is $5,188 today. The worst was 2019-02 ($20,621): $1,000 then is $1.01.
FAQ
What would $1,000 in AVTX be worth today?
A $1,000 investment in Avalo Therapeutics, Inc. (AVTX) at the start of 2015 would be worth about $1.26 today, a total return of -99.9%. Dividends are reinvested in these figures.
What were the best and worst years for AVTX?
Avalo Therapeutics, Inc. (AVTX)'s strongest calendar year since 2015 was 2017, a +263.6% return — $1,000 held through that year became about $3,636 by year-end. Its weakest year was 2023, at -99.2%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in AVTX have grown?
Investing $100 at the end of every month since 2015-10 would have grown to about $7,683 on $13,100 invested.
Did AVTX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $3,707. AVTX trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Avalo Therapeutics, Inc. (AVTX) historical total-return data from 2015-10 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.